187 related articles for article (PubMed ID: 32161581)
1. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Bartres C; González P; García-López M; Pose E; Lens S; Maini MK; Forns X; Koutsoudakis G
Front Immunol; 2020; 11():129. PubMed ID: 32161581
[No Abstract] [Full Text] [Related]
2. Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.
Serti E; Chepa-Lotrea X; Kim YJ; Keane M; Fryzek N; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2015 Jul; 149(1):190-200.e2. PubMed ID: 25754160
[TBL] [Abstract][Full Text] [Related]
3. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.
Edlich B; Ahlenstiel G; Zabaleta Azpiroz A; Stoltzfus J; Noureddin M; Serti E; Feld JJ; Liang TJ; Rotman Y; Rehermann B
Hepatology; 2012 Jan; 55(1):39-48. PubMed ID: 21898483
[TBL] [Abstract][Full Text] [Related]
4. Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir.
Wang XX; Luo BF; Jiang HJ; Cong X; Jin Q; Ma DL; Wei L; Feng B
World J Gastroenterol; 2018 Oct; 24(40):4554-4564. PubMed ID: 30386105
[TBL] [Abstract][Full Text] [Related]
5. Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.
Serti E; Park H; Keane M; O'Keefe AC; Rivera E; Liang TJ; Ghany M; Rehermann B
Gut; 2017 Apr; 66(4):724-735. PubMed ID: 26733671
[TBL] [Abstract][Full Text] [Related]
6. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Ahlenstiel G; Titerence RH; Koh C; Edlich B; Feld JJ; Rotman Y; Ghany MG; Hoofnagle JH; Liang TJ; Heller T; Rehermann B
Gastroenterology; 2010 Jan; 138(1):325-35.e1-2. PubMed ID: 19747917
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
9. Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.
Spaan M; van Oord G; Kreefft K; Hou J; Hansen BE; Janssen HL; de Knegt RJ; Boonstra A
J Infect Dis; 2016 Jan; 213(2):216-23. PubMed ID: 26223768
[TBL] [Abstract][Full Text] [Related]
10. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment.
Bozzano F; Picciotto A; Costa P; Marras F; Fazio V; Hirsch I; Olive D; Moretta L; De Maria A
Eur J Immunol; 2011 Oct; 41(10):2905-14. PubMed ID: 21695691
[TBL] [Abstract][Full Text] [Related]
11. Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients.
Jiang HJ; Wang XX; Luo BF; Cong X; Jin Q; Qin H; Zhang HY; Kong XS; Wei L; Feng B
Clin Exp Med; 2019 Aug; 19(3):299-308. PubMed ID: 31218578
[TBL] [Abstract][Full Text] [Related]
12. Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients.
Mele D; Oliviero B; Mantovani S; Ludovisi S; Lombardi A; Genco F; Gulminetti R; Novati S; Mondelli MU; Varchetta S
Hepatology; 2021 Jan; 73(1):79-90. PubMed ID: 32281670
[TBL] [Abstract][Full Text] [Related]
13. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
[TBL] [Abstract][Full Text] [Related]
14. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
[TBL] [Abstract][Full Text] [Related]
15. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use.
Hotho DM; Kreefft K; Groothuismink ZM; Janssen HL; de Knegt RJ; Boonstra A
Antiviral Res; 2013 Mar; 97(3):347-55. PubMed ID: 23291200
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients.
Adenugba A; Hornung M; Weigand K; Peschel G; Junger H; Kupke P; Lang H; Marquardt JU; Zimmermann T; Geissler EK; Schlitt HJ; Werner JM
Transplantation; 2021 Oct; 105(10):2226-2238. PubMed ID: 33587435
[TBL] [Abstract][Full Text] [Related]
18. Association of NKG2A with treatment for chronic hepatitis C virus infection.
Harrison RJ; Ettorre A; Little AM; Khakoo SI
Clin Exp Immunol; 2010 Aug; 161(2):306-14. PubMed ID: 20550548
[TBL] [Abstract][Full Text] [Related]
19. [Effect of gMDSCs on natural killer cell functionality in chronic hepatitis C patients treated with direct-acting antiviral agents].
Shi JJ; Zhou WJ; Lu C; Jia XY; Chang WX; Zhang JY; Li YY; Mu XL
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2133-2139. PubMed ID: 34275248
[No Abstract] [Full Text] [Related]
20. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.
Glässner A; Eisenhardt M; Krämer B; Körner C; Coenen M; Sauerbruch T; Spengler U; Nattermann J
Lab Invest; 2012 Jul; 92(7):967-77. PubMed ID: 22449797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]